Application Information

This drug has been submitted to the FDA under the reference 205941/001.

Names and composition

"SAXAGLIPTIN" is the commercial name of a drug composed of SAXAGLIPTIN.
It belongs to the class Dipeptidyl peptidase 4 inhibitors and is used in Oral and parenteral hypoglycaemics (Diabetes)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205941/001 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 2.5MG
205941/002 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 5MG
205959/002 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 5MG
205972/001 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 2.5MG
205972/002 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 5MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
205941/001 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 2.5MG
205941/002 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 5MG
205959/002 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 5MG
205972/001 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 2.5MG
205972/002 SAXAGLIPTIN SAXAGLIPTIN TABLET/ORAL 5MG

Manufacturers

Manufacturer name
AstraZeneca UK Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved